Qualification
2547
อ.ว. กุมารเวชศาสตร์โรคติดเชื้อ แพทยสภา
มหาวิทยาลัยเชียงใหม่
ประเทศไทย
2545
Fellowship in Infectious Diseases
Johns Hopkins Bloomberg School of Public Health
USA
2544
Master of Health Science (MHS) in Clinical Investigation
Johns Hopkins University
USA
2543
อ.ว. กุมารเวชศาสตร์ แพทยสภา
มหาวิทยาลัยเชียงใหม่
ประเทศไทย
2539
แพทยศาสตรบัณฑิต
จุฬาลงกรณ์มหาวิทยาลัย
ประเทศไทย
Selected Publications
2026
Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial. Open Forum Infect Dis. 2026 May 5;13(5):ofag266.
2025
Viral Suppression, Viral Failure, and Safety Outcomes in Children and Adolescents With HIV on Dolutegravir in Europe and Thailand. Clin Infect Dis. 2025 Nov 6;81(4):e115-e127.
2025
Long-acting PrEP for adolescent girls and young women. Songtaweesin WN, Puthanakit T. Lancet HIV. 2025 Apr;12(4):e240-e241
2024
The urgency of now to end HIV vertical transmission for pregnant and breastfeeding women and their children in Asia and the Pacific. Lancet Reg Health West Pac. 2024 Dec 1;53:101248.
2024
A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial. Lancet Child Adolesc Health. 2024 Dec;8(12):900-909.
2023
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial. Lancet Child Adolesc Health. 2023 Oct;7(10):718-727.
2023
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women. Vaccine. 2023 Jul 12;41(31):4541-4553.
2023
Long-term outcomes of rapid antiretroviral NNRTI-based initiation among Thai youth living with HIV: a national registry database study. J Int AIDS Soc. 2023 Mar;26(3):e26071.
2023
Hybrid immunity from SARS-CoV-2 infection and mRNA BNT162b2 vaccine among Thai school-aged children. Vaccine X. 2023 Nov 24;15:100414.
2018
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. N Engl J Med. 2018 Mar 8;378(10):911-923.
